US EditionWhistleblowers to Receive Up to $920K after Alleging Fraud in Breast Cancer Testing
Summary by Front Line Whistleblower News
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Whistleblowers to Receive Up to $920K after Alleging Fraud in Breast Cancer Testing
On May 21, the U.S. Attorney for the Eastern District of Tennessee announced that Agendia, Inc., a global molecular diagnostics company that offers genomic testing designed to profile certain types of breast cancer, agreed to pay the government at least $3,250,000 to settle allegations that it violated the False Claims Act (FCA). The settlement stems […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
